The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of a COVID-19 vaccine candidate, developed by the...
from NDTV News - Latest https://www.ndtv.com/india-news/serum-institute-gets-nod-for-phase-2-3-human-trial-of-oxford-covid-vaccine-2273078
No comments:
Post a Comment